Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCL2 rs1024611Gene Polymorphism in Philadelphia-Negative Myeloproliferative Neoplasms.

Genes - 10 Mar 2022

Hodeib Hossam, Abd El Hai Dina, Tawfik Mohamed A, Allam Alzahraa A, Selim Amal, Elsawy Abdallah Ahmed, Youssef Amira

Abstract excerpt

Introduction: The onset of the Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) is caused by acquired somatic mutations in target myeloid genes “driver mutations”. The CCL2 gene is overexpressed by non-Hodgkin lymphomas and multiple solid tumors. Aim of the study: to evaluate the possible association of CCL2 rs1024611 SNP and its expression level and the risk of developing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine CCL2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Myeloproliferative Disorders

Share to Polycythemia Vera

Share to Polymorphism, Genetic

Share to Primary Myelofibrosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35328046
DOI: 10.3390/genes13030492
PMCID: PMC8948730

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

CCL2 rs1024611Gene Polymorphism in Philadelphia-Negative Myeloproliferative Neoplasms.PMID 35328046Read ↗

Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms.Semantic proximity Read ↗

Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.Semantic proximity Read ↗

Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.Semantic proximity Read ↗

Prevalence of MPL W515L/K mutations in Taiwanese patients with Philadelphia-negative chronic myeloproliferative neoplasms.Semantic proximity Read ↗

Toll-like receptor gene polymorphisms in patients with myeloproliferative neoplasms.Semantic proximity Read ↗

The Role of Caspase Genes Polymorphisms in Genetic Susceptibility to Philadelphia-Negative Myeloproliferative Neoplasms in a Portuguese Population.Semantic proximity Read ↗

The JAK2 46/1 haplotype influences PD-L1 expressionSemantic proximity Read ↗

Predictive Value of miR-146a rs2431697 Polymorphism to Myelofibrosis Progression in Patients with Myeloproliferative Neoplasm.Semantic proximity Read ↗

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.Semantic proximity Read ↗

[JAK2V617F mutation and TNF-α expression in myeloproliferative neoplasms and their correlation].Semantic proximity Read ↗

TLR-2 derangements likely play a significant role in the inflammatory response and thrombosis in patients with Ph(-) classical myeloproliferative neoplasmSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.